Julie Napieralski

Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte Studies

Dragana Bugarski‐Kirola, Thomas Blaettler, Celso Arango et al. · Biological Psychiatry · 2016 · 139 citations

Medicine, Pharmacology, Psychiatry +13

Anatomical and functional evidence for lesion-specific sprouting of corticostriatal input in the adult rat

Julie Napieralski, Andrew Butler, M.‐F. Chesselet · The Journal of Comparative Neurology · 1996 · 131 citations

Medicine, Neurobiology, Neuroscience +17

The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury

Julie Napieralski, Ramesh Raghupathi, Tracy K. McIntosh · Molecular Brain Research · 1999 · 105 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies

Lori Mayer, Ludwig Kappos, Michael K. Racke et al. · Multiple Sclerosis and Related Disorders · 2019 · 97 citations

Pharmacy, Neurology, Pharmacotherapy +10

Novel developmental boundary in the cerebellum revealed by zebrin expression in the <i>Lurcher</i> (<i>Lc</i>/+) mutant mouse

David Tano, Julie Napieralski, Leonard M. Eisenman et al. · The Journal of Comparative Neurology · 1992 · 83 citations

Medicine, Neurobiology, Neuroscience +17